The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Clorox has lowered its full-year adjusted earnings guidance to a range of $5.45 to $5.65 per share, extending its cautious financial outlook through fiscal year 2026 (FY26). The company attributed the revision to declines in its Lifestyle segment and a spike in manufacturing and logistics expenses. Additionally, costs associated with the GOJO acquisition have further pressured profit margins, contributing to CLX shares hitting a 52-week low. Management anticipates a significant contraction in annual gross margins as consumers become increasingly selective amid persistent inflationary pressures. This update highlights the operational challenges and integration costs currently weighing on the consumer staples giant. Investors remain focused on the company's ability to navigate rising input costs and stabilize its long-term earnings trajectory.
Sign in to access this content
Sign In